(Q37274331)

19 August 2017

1 reference

title

Allograft and bone morphogenetic proteins: an overview (English)

1 reference

19 August 2017

1 reference

T J Blokhuis

1

1 reference

19 August 2017

T Lindner

series ordinal

2

1 reference

19 August 2017

publication date

1 September 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

39 Suppl 2

1 reference

19 August 2017

page(s)

S33-6

1 reference

Transmission of disease through transplantation of musculoskeletal allografts

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Bone substitutes: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Effect of low dose and moderate dose gamma irradiation on the mechanical properties of bone and soft tissue allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Current trends in bone grafting and the issue of banked bone allografts based on the fourth nationwide survey of bone grafting status from 2000 to 2004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Clostridium infections associated with musculoskeletal-tissue allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Detection of living cells in non-processed but deep-frozen bone allografts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Bone grafting for spinal fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Allograft update: the current status of tissue regulation, procurement, processing, and sterilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Gamma irradiation of human bone allografts alters medullary lipids and releases toxic compounds for osteoblast-like cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Graft incorporation after acetabular and femoral impaction grafting with washed irradiated allograft and autologous marrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Femoral impaction grafting in revision hip arthroplasty with irradiated bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Tissue response and osteoinduction of human bone grafts in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Commercially-prepared allograft material has biological activity in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Long-term results of allograft replacement in the management of bone tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

An ongoing research for evaluation of treatment with BMPs or AGFs in long bone non-union: protocol description and preliminary results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Clinical applications of BMPs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Application of recombinant BMP-7 on persistent upper and lower limb non-unions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Clinical applications of BMP-7: the UK perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Biological enhancement of tibial diaphyseal aseptic non-unions: the efficacy of autologous bone grafting, BMPs and reaming by-products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Recombinant human bone morphogenetic protein-7 for treatment of long bone non-union: an observational, retrospective, non-randomized study of 105 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Use of bone morphogenetic proteins for treatment of non-unions and future perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Bone morphogenic protein and its application in trauma cases: a current concept update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Extracortical bone-bridging fixation with use of cortical allograft and recombinant human osteogenic protein-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Repair of bone allograft fracture using bone morphogenetic protein-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

The effect of recombinant human bone morphogenetic protein-2 on femoral reconstruction with an intercalary allograft in a dog model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

The effect of osteogenic protein-1 on the healing of segmental bone defects treated with autograft or allograft bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Addition of human recombinant bone morphogenetic protein-2 to inactive commercial human demineralized freeze-dried bone allograft makes an effective composite bone inductive implant material

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Cantilever TLIF with structural allograft and RhBMP2 for correction and maintenance of segmental sagittal lordosis: long-term clinical, radiographic, and functional outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

Impacted cancellous allografts and cement for revision total hip arthroplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970013-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0020-1383(08)70013-5

1 reference

19 August 2017

1 reference